Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment
I tiakina i:
Nosyk, B., ET AL., Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. Canadian Medical Association Journal, Vol. 184, no. 6 (2012), p. 17-28.
Ref.
185853
Tauwāhi:
SIIS Archivo
Palabras clave:
Alternativas, Análisis coste-eficacia, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Programas de mantenimiento, Reducción de daños, Resultados, Tratamiento médico, Canadá
Alternativas, Análisis coste-eficacia, Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Metadona, Opiáceos, Programas de mantenimiento, Reducción de daños, Resultados, Tratamiento médico, Canadá
Ngā tūemi rite: Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment
- DIACETYLMORPHINE VERSUS METHADONE FOR THE TREATMENT OF OPIOID ADDICTION
- EFFECTIVENESS OF DIACETYLMORPHINE VERSUS METHADONE FOR THE TREATMENT OF OPIOID DEPENDENCE IN WOMEN
- COST ANALYSIS OF CLINIC AND OFFICE-BASED TREATMENT OF OPIOID DEPENDENCE: RESULTS WITH METHADONE AND BUPRENORPHINE IN CLINICALLY STABLE PATIENTS
- The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency
- DAY TREATMENT VERSUS ENHANCED STANDARD METHADONE SERVICES FOR OPIOID-DEPENDENT PATIENTS: A COMPARISON OF CLINICAL EFFICACY AND COST
- DOUBLE BLIND INJECTABLE HYDROMORPHONE VERSUS DIACETYLMORPHINE FOR THE TREATMENT OF OPIOID DEPENDENCE: A PILOT STUDY